scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0301-472X(98)00070-8 |
P698 | PubMed publication ID | 10210333 |
P50 | author | Wolf Hervé Fridman | Q40876588 |
P2093 | author name string | A Boyer | |
J L Teillaud | |||
J L Romet-Lemonne | |||
G Andreu | |||
P2860 | cites work | Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products | Q24678867 |
Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution | Q24679240 | ||
Dendritic cells and the control of immunity | Q27860918 | ||
Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses | Q28115227 | ||
Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha | Q28251443 | ||
Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor | Q36352014 | ||
Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures | Q36376739 | ||
Vitamin D metabolites change the phenotype of monoblastic U937 cells | Q37507817 | ||
CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells | Q37698653 | ||
Immune interferon: a pleiotropic lymphokine with multiple effects | Q38257547 | ||
The endocytic activity of dendritic cells. | Q40457008 | ||
Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 | ||
Nonopsonic phagocytosis of microorganisms | Q40945108 | ||
Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs | Q41057373 | ||
Both mannose and beta-glucan receptors are involved in phagocytosis of unopsonized, heat-killed Saccharomyces cerevisiae by murine macrophages. | Q41511489 | ||
Functional significance of induction of differentiation in human myeloid leukaemic blasts by 1,25-dihydroxyvitamin D3 and GM-CSF. | Q41648870 | ||
Identification of a novel cell type in peripheral lymphoid organs of mice. II. Functional properties in vitro | Q42022012 | ||
Identification of a novel cell type in peripheral lymphoid organs of mice. 3. Functional properties in vivo | Q42837010 | ||
Dendritic cells hold promise for immunotherapy | Q43811691 | ||
Expression and function of B7-1 (CD80) and B7-2 (CD86) on human epidermal Langerhans cells | Q56909136 | ||
A New Set of Monoclonal Antibodies Against Human FcγRII (CD32) and FcγRIII (CD16): Characterization and Use in Various Assays | Q56933170 | ||
Expression of a mannose/fucose membrane lectin on human dendritic cells | Q62091158 | ||
Adoptive immunotherapy with bispecific antibodies: targeting through macrophages | Q68054829 | ||
The human mononuclear phagocyte high-affinity Fc receptor, FcRI, defined by a monoclonal antibody, 10.1. | Q68832703 | ||
Isolation and characterization of a mannan-binding protein from human serum | Q71104404 | ||
Mannose binding protein (MBP) enhances mononuclear phagocyte function via a receptor that contains the 126,000 Mr component of the Clq receptor | Q71800454 | ||
The emergence of cell therapy in France. Public health, regulations and other controversial issues | Q73834326 | ||
Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells | Q74310288 | ||
P433 | issue | 4 | |
P304 | page(s) | 751-761 | |
P577 | publication date | 1999-04-01 | |
P1433 | published in | Experimental Hematology | Q5421109 |
P1476 | title | Generation of phagocytic MAK and MAC-DC for therapeutic use: characterization and in vitro functional properties | |
P478 | volume | 27 |
Q64380597 | Adenoviral transduction of human 'clinical grade' immature dendritic cells enhances costimulatory molecule expression and T-cell stimulatory capacity |
Q78025878 | Advantages of hydrophobic culture bags over flasks for the generation of monocyte-derived dendritic cells for clinical applications |
Q45884227 | Bypassing tumor-specific and bispecific antibodies: triggering of antitumor immunity by expression of anti-FcgammaR scFv on cancer cell surface |
Q56966277 | Cytokine production and T-cell activation by macrophage-dendritic cells generated for therapeutic use |
Q35219327 | Dendritic cells and fungi |
Q74336550 | Differentiation of antigen-presenting cells (dendritic cells and macrophages) for therapeutic application in patients with lymphoma |
Q35849709 | Efficient inhibition of HIV-1 replication in human immature monocyte-derived dendritic cells by purified anti-HIV-1 IgG without induction of maturation |
Q39316685 | Engineering macrophages to eat cancer: from "marker of self" CD47 and phagocytosis to differentiation. |
Q39601286 | Functional and selective targeting of adenovirus to high-affinity Fcgamma receptor I-positive cells by using a bispecific hybrid adapter |
Q34329143 | Human macrophages and dendritic cells can equally present MART-1 antigen to CD8(+) T cells after phagocytosis of gamma-irradiated melanoma cells |
Q24808841 | IL-12 Production Induced by Agaricus blazei Fraction H (ABH) Involves Toll-like Receptor (TLR) |
Q79106279 | Immunophenotype and functional properties of feline dendritic cells derived from blood and bone marrow |
Q36206601 | Immunotherapy in multiple myeloma--possibility or probability? |
Q64253571 | The Role of the Immune System in Cutaneous Squamous Cell Carcinoma |
Q78733406 | [Cancer genetic immunotherapy] |
Search more.